Ferrous sulphate: replace iron only after you have identified iron deficiency—and find out why it occurred
Ferrous sulphate is an oral ferrous (Fe²⁺) salt used to prevent or treat iron deficiency. It supplies elemental iron for haemoglobin synthesis and repletion of body iron stores. It is excellent therapy for confirmed or strongly suspected iron deficiency anaemia (IDA), but it is not a treatment for every low haemoglobin. The safest clinical sequence is: recognise anaemia → confirm iron deficiency where possible → look for the cause → choose and monitor iron therapy.
Learning outcomes
By the end, you should be able to explain iron handling, interpret the core tests for IDA, convert a ferrous-sulphate strength to elemental iron, give practical oral-iron instructions, detect non-response or toxicity, and distinguish cases that need investigation, referral or intravenous iron.
1. The one-minute clinical map
| Clinical question | High-yield answer |
|---|---|
| What does it treat? | Iron deficiency with or without anaemia; prevention only in selected groups following local/WHO protocols. |
| What matters on the packet? | Elemental iron, not just the mass of the salt. Check the local formulation and label. |
| What usually confirms depleted stores? | Low serum ferritin in an appropriate clinical context. Ferritin rises with inflammation, infection and liver disease, so a “normal” ferritin may mislead. |
| What is the main error? | Giving iron indefinitely without investigating blood loss, poor intake, malabsorption, inflammation or another cause of anaemia. |
| Most common adverse effects? | Nausea, epigastric discomfort, constipation or diarrhoea; dark stools are common. |
| Danger signal? | Iron overdose in a child is an emergency. Keep all iron products locked away and seek urgent help after a suspected ingestion. |
2. Why the body needs iron
Transport and storage
Most functional iron is in haemoglobin; it carries oxygen. Iron is also in myoglobin and iron-containing enzymes. Circulating iron is carried by transferrin; reserve iron is mainly stored as ferritin.
Absorption
Non-haem iron is absorbed mainly in the duodenum and proximal jejunum. Ferrous iron is generally absorbed more readily than ferric iron. Acidic conditions and vitamin-C-containing food can favour absorption; several foods and medicines reduce it.
Hepcidin
Hepcidin reduces intestinal iron export and macrophage iron release. It rises with inflammation and can make oral iron less effective even when total-body iron is present.
3. Do not call every anaemia “iron deficiency”
Anaemia is a finding, not a diagnosis. IDA is common, but microcytosis may also occur with thalassaemia traits, anaemia of inflammation and other disorders. Macrocytosis suggests a different pathway such as folate/B12 deficiency, medicines, liver disease or marrow disease. A normocytic anaemia may be early iron deficiency, blood loss, renal disease, inflammation or haemolysis.
Core pre-treatment assessment
- History: fatigue, dyspnoea, pica, diet, pregnancy, menstrual loss, post-partum bleeding, GI symptoms, melena, medicines (including NSAIDs), previous surgery, malabsorption risk, deworming/parasite exposure and family history.
- Examination: pallor, pulse, heart-failure signs, glossitis/cheilitis, abdominal findings and signs of ongoing bleeding or systemic disease.
- Tests when available: full blood count (Hb, MCV, MCH, RDW), ferritin, peripheral film; add transferrin saturation/CRP where inflammation is likely. Reticulocyte count, renal profile, B12/folate, stool/GI work-up or haemoglobinopathy testing are directed by the case.
Important: in adult men and post-menopausal women, IDA commonly requires evaluation for gastrointestinal blood loss unless there is an obvious alternative explanation. In menstruating patients and pregnancy, do not simply assume the cause—assess the bleeding, diet and clinical context.
4. Ferrous sulphate and elemental-iron mathematics
Ferrous sulphate is a salt; the therapeutic component is elemental iron. Common preparations differ in hydration, coating and local strength. A frequently encountered example is 325 mg ferrous sulphate ≈ 65 mg elemental iron, but this is not universal. Always read the product label or formulary before prescribing, dispensing or teaching a dose.
| Oral iron salt | What students must compare | Practical point |
|---|---|---|
| Ferrous sulphate | Salt strength, elemental iron per tablet/5 mL, release formulation | Widely available and inexpensive; GI intolerance often limits adherence. |
| Ferrous fumarate | Usually more elemental iron per mass of salt | Not automatically “stronger” clinically; compare elemental iron and tolerance. |
| Ferrous gluconate/other ferrous salts | Elemental iron per unit and dosing schedule | May be selected for formulation or tolerance; evidence of benefit depends on adherence and absorption. |
5. Oral treatment: dosing principles, not a one-size-fits-all prescription
For established IDA, prescribe in elemental iron and follow the local guideline/formulary. Many adult regimens use a single daily dose of a ferrous salt; some patients are managed on alternate days or with a lower dose to improve tolerance and adherence. More tablets are not always better: unabsorbed iron increases gastrointestinal adverse effects and hepcidin biology may limit absorption.
- Do not confuse prevention with treatment. WHO recommends daily oral iron plus folic acid in pregnancy for prevention in relevant settings (30–60 mg elemental iron with 400 micrograms folic acid daily); treat confirmed anaemia using the applicable ANC/clinical protocol.
- Children: use weight-based elemental-iron dosing under paediatric/local guidance; avoid “adult tablet fractions” without checking the product and the protocol.
- Severe symptomatic anaemia, haemodynamic compromise, active bleeding, chest pain, syncope or heart failure signs: this is urgent clinical assessment, not routine outpatient iron counselling.
6. How to take ferrous sulphate well
Timing
Absorption is usually best away from food, but take with a small meal if nausea or pain would otherwise make adherence impossible. Do not stop treatment silently because of side effects—adjust the plan with a clinician.
What to separate
Ask specifically about antacids, calcium, tea/coffee, dairy, tetracyclines, quinolones, levothyroxine and other medicines. Spacing requirements vary: check the product and medicine-specific advice. Levothyroxine and iron are commonly separated by at least four hours.
Liquid preparations
They can stain teeth. Dilute as directed, use a straw where appropriate and rinse/brush after the dose. Keep the bottle closed and out of a child’s reach.
Counselling sentence for exams: “Take exactly as prescribed; empty stomach improves absorption but food is acceptable for troublesome GI effects. Keep it separate from absorption-interfering products. Expect darker stools, but seek assessment for sticky tarry stools, faintness, severe abdominal pain or suspected bleeding.”
7. Expected response and how to monitor it
| Time point | What to look for | What poor response means |
|---|---|---|
| Before treatment | Hb, indices, ferritin when possible; assess cause and severity | Do not miss bleeding, inflammation, haemoglobinopathy, B12/folate deficiency or renal disease. |
| About 1 week | Clinical improvement; reticulocytosis may be seen if tested | Check adherence, dose/formulation, vomiting, interactions and ongoing loss. |
| 2–4 weeks | Haemoglobin should rise if diagnosis, absorption and adherence are correct | Reassess rather than simply escalating tablets. |
| After Hb correction | Continue for a clinician-directed period to rebuild stores; repeat Hb/ferritin as appropriate | Early stopping corrects Hb but may leave iron stores depleted and recurrence likely. |
Reasons oral iron appears to “fail”
- Incorrect diagnosis or mixed anaemia.
- Missed doses because of adverse effects, cost or misunderstanding.
- Wrong elemental-iron calculation or poor timing with inhibitors/interacting medicines.
- Ongoing heavy menstrual, obstetric or gastrointestinal blood loss.
- Malabsorption: coeliac disease, gastric/intestinal surgery, chronic gastritis, H. pylori or inflammatory bowel disease.
- Inflammation/CKD with raised hepcidin and functional iron restriction.
8. Adverse effects, cautions and contraindications
| Issue | Recognise it | Safe response |
|---|---|---|
| Common GI effects | Nausea, abdominal discomfort, constipation or diarrhoea | Review dose, schedule and administration; do not abandon the search for the cause of anaemia. |
| Dark stool | Common with oral iron | Explain in advance. Differentiate from melena: black, tarry, sticky stool with systemic symptoms needs assessment. |
| Teeth staining | With liquids | Administration technique and oral hygiene; do not leave liquid within reach of children. |
| Iron overload | Haemochromatosis/haemosiderosis or repeated inappropriate supplementation | Avoid empiric long-term iron; investigate before replacing iron in unexplained anaemia. |
| Active significant GI disease | Pain, ulcer symptoms, IBD activity or intolerance | Individualise; consult the relevant clinician/protocol. |
9. When intravenous iron or referral may be appropriate
Oral therapy is usually first-line when absorption is expected and the patient is stable. Consider specialist assessment/IV iron where oral iron is not tolerated, cannot be absorbed, cannot keep up with ongoing loss, is ineffective despite verified adherence and diagnosis, or a faster repletion strategy is clinically necessary. IV iron is a treatment with its own dose calculation, monitoring and hypersensitivity precautions; it is not a casual substitution.
10. Acute iron poisoning: a must-not-miss emergency
Accidental iron ingestion can be fatal in young children. Early features include vomiting, abdominal pain, diarrhoea and lethargy; severe poisoning can progress to shock, acidosis, hepatic injury, coma and death. Do not wait for symptoms after a potentially significant ingestion: arrange emergency assessment/poison advice immediately, take the container if safe, and never induce vomiting unless directed by emergency professionals.
11. Case-based application
Case 1 — fatigue and microcytosis
A 22-year-old with heavy menses has Hb 8.9 g/dL, low MCV and low ferritin. The working diagnosis is IDA, but the plan also asks about bleeding severity, pregnancy possibility, diet and haemodynamic symptoms. Start an elemental-iron-based regimen under protocol, give interaction/side-effect counselling, arrange review, and address the source of blood loss.
Case 2 — no rise in Hb
A patient says they have taken “iron tablets” for six weeks but Hb is unchanged. Do not merely double the dose. Verify elemental iron, actual adherence and timing with tea/antacids/calcium; review medicines and ongoing bleeding; reconsider the diagnosis and investigate malabsorption or inflammation.
Case 3 — black stool
After starting iron, a stable patient reports darker stools but no weakness, dizziness, abdominal pain or tarry sticky stool. This is a predictable effect and should be explained. If stool is truly melaena or symptoms suggest bleeding, assess urgently rather than attributing everything to iron.
12. Exam-ready high-yield facts
- Ferrous salts provide Fe²⁺; dose using elemental iron.
- Ferritin reflects iron stores but is an acute-phase reactant.
- IDA commonly gives low Hb, low MCV/MCH and raised RDW, but the complete pattern and cause matter.
- Oral iron is not harmless: interactions, GI intolerance and overdose must be anticipated.
- Dark stools are expected; melena is not.
- A good Hb response does not remove the duty to identify why iron deficiency happened.
13. Further study and sources
- Course reference: Haematinics: ferrous sulphate, ferrous fumarate and related preparations (SlideShare).
- WHO: daily iron and folic acid supplementation during pregnancy.
- MedlinePlus: Iron Supplements: drug information.
- NIH DailyMed: Ferrous sulfate label and safety information.
- Fertrin KY. Diagnosis and management of iron deficiency in chronic inflammatory conditions.
Educational resource: apply current national guidelines, local formulary details and senior clinical supervision to individual patients.
